Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Birinapant and IMRRT for Locoregionally Recurrent HNSCC

Protocol: OSU-19010

Full Title

Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

Head & Neck Cancers Squamous Cell Carcinoma